Takami Sato
- Oncology top 1%
- Ophthalmology top 0.2%
- Immunology top 2%
- Molecular Biology top 5%
- Pulmonary and Respiratory Medicine top 5%
- Co-authors
- Michael J. MastrangeloMizue TeraiDavid BerdJerry A. ShieldsCarol L. ShieldsMarlana OrloffDavid J. EschelmanCarin F. Gonsalves
- Topics
- Ocular Oncology and Treatments (97 papers)Immunotherapy and Immune Responses (60 papers)Cancer Immunotherapy and Biomarkers (20 papers)
- Cited by
- OphthalmologyImmunologyOncology
- Partner nations
- United StatesJapanUnited Kingdom
In The Last Decade
Takami Sato
168 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Oncology 1.7k
- Ophthalmology 1.6k
- Immunology 1.4k
- Molecular Biology 1.3k
- Pulmonary and Respiratory Medicine 390
Countries citing papers authored by Takami Sato
This map shows the geographic impact of Takami Sato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takami Sato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takami Sato more than expected).
Fields of papers citing papers by Takami Sato
This network shows the impact of papers produced by Takami Sato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takami Sato. The network helps show where Takami Sato may publish in the future.
Co-authorship network of co-authors of Takami Sato
This figure shows the co-authorship network connecting the top 25 collaborators of Takami Sato. A scholar is included among the top collaborators of Takami Sato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takami Sato. Takami Sato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 2 | |
| 7 | 7 | |
| 8 | 9 | |
| 9 | 3 | |
| 10 | 3 | |
| 11 | 37 | |
| 12 | 54 | |
| 13 | 18 | |
| 14 | 69 | |
| 15 | 54 | |
| 16 | Safety, efficacy and biology of the gp100 TCR-based bispecific T cell redirector IMCgp100 in advanced uveal melanoma | 5 |
| 17 | 53 | |
| 18 | 9 | |
| 19 | 19 | |
| 20 | Effects of parotid gland extract (Parotin) upon the calcification of rabbit dentine and bone. | 2 |
About Takami Sato
Takami Sato is a scholar working on Ophthalmology, Immunology and Oncology, having authored 179 papers that have together received 3.8k indexed citations. Recurring topics across this work include Ocular Oncology and Treatments (97 papers), Immunotherapy and Immune Responses (60 papers) and Cancer Immunotherapy and Biomarkers (20 papers). The work is most often cited by research in Ophthalmology (1.6k citations), Immunology (1.4k citations) and Oncology (1.7k citations). Takami Sato has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Michael J. Mastrangelo, Mizue Terai, David Berd, Jerry A. Shields, Carol L. Shields, Marlana Orloff, David J. Eschelman, Carin F. Gonsalves, Lauren A. Dalvin and Kevin L. Sullivan. Their work appears in journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.